Astrocytes Derived from p53-Deficient Mice Provide a Multistep In Vitro Model for Development of Malignant Gliomas
Open Access
- 1 August 1995
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 15 (8) , 4249-4259
- https://doi.org/10.1128/mcb.15.8.4249
Abstract
Loss or mutation of p53 is thought to be an early event in the malignant transformation of many human astrocytic tumors. To better understand the role of p53 in their growth and transformation, we developed a model employing cultured neonatal astrocytes derived from mice deficient in one (p53 +/-) or both (p53 -/-) p53 alleles, comparing them with wild-type (p53 +/+) cells. Studies of in vitro and in vivo growth and transformation were performed, and flow cytometry and karyotyping were used to correlate changes in growth with genomic instability. Early-passage (EP) p53 -/- astrocytes achieved higher saturation densities and had more rapid growth than EP p53 +/- and +/+ cells. The EP p53 -/- cells were not transformed, as they were unable to grow in serum-free medium or in nude mice. With continued passaging, p53 -/- cells exhibited a multistep progression to a transformed phenotype. Late-passage p53 -/- cells achieved saturation densities 50 times higher than those of p53 +/+ cells and formed large, well-vascularized tumors in nude mice. p53 +/- astrocytes exhibited early loss of the remaining wild-type p53 allele and then evolved in a manner phenotypically similar to p53 -/- astrocytes. In marked contrast, astrocytes retaining both wild-type p53 alleles never exhibited a transformed phenotype and usually senesced after 7 to 10 passages. Dramatic alterations in ploidy and karyotype occurred and were restricted to cells deficient in wild-type p53 following repeated passaging. The results of these studies suggest that loss of wild-type p53 function promotes genomic instability, accelerated growth, and malignant transformation in astrocytes.Keywords
This publication has 52 references indexed in Scilit:
- Patterns of the early, gross chromosomal changes in malignant human gliomasHereditas, 2008
- p53 Mutation, Expression, and DNA Ploidy in Evolving Gliomas: Evidence for Two Pathways of ProgressionJNCI Journal of the National Cancer Institute, 1994
- Tumor spectrum analysis in p53-mutant miceCurrent Biology, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53Published by Elsevier ,1992
- Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 allelesCell, 1992
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- Genetics of the malignant progression of astrocytomaJournal of Cellular Biochemistry, 1991
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981